Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Menko

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Journal of Clinical Pathology|June 23, 2009
Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriersP van der Groep, P J van Diest, F H Menko, et al.
Clinical Genetics|April 2, 2015
Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletionJ A Rijken, N D Niemeijer, E P M Corssmit, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 familiesH F Vasen, B G Taal, F M Nagengast, et al.
Cancer Research|June 1, 1996
Inheritance of abnormal expression of SOS-like response in xeroderma pigmentosum and hereditary cancer-prone syndromesP J Abrahams, A Houweling, D M Cornelissen-Steijger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer familiesH F Vasen, A Stormorken, F H Menko, et al.
Cancer|May 12, 1998
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriersH F Vasen, M van Ballegooijen, E Buskens, et al.
Gut|May 13, 2003
Rapidly progressive adenomatous polyposis in a patient with germline mutations in both the APC and MLH1 genes: the worst of two worldsR Scheenstra, F E M Rijcken, J J Koornstra, et al.
Clinical Genetics|December 1, 2010
Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test resultsJ Vos, J C Oosterwijk, E Gómez-García, et al.
Gynecologic Oncology|January 6, 2000
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.
International Journal of Cancer|July 15, 1990
The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the NetherlandsH F Vasen, G J Offerhaus, F C den Hartog Jager, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Journal of Clinical Pathology|June 23, 2009
Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriersP van der Groep, P J van Diest, F H Menko, et al.
Clinical Genetics|April 2, 2015
Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletionJ A Rijken, N D Niemeijer, E P M Corssmit, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 familiesH F Vasen, B G Taal, F M Nagengast, et al.
Cancer Research|June 1, 1996
Inheritance of abnormal expression of SOS-like response in xeroderma pigmentosum and hereditary cancer-prone syndromesP J Abrahams, A Houweling, D M Cornelissen-Steijger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer familiesH F Vasen, A Stormorken, F H Menko, et al.
Cancer|May 12, 1998
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriersH F Vasen, M van Ballegooijen, E Buskens, et al.
Gut|May 13, 2003
Rapidly progressive adenomatous polyposis in a patient with germline mutations in both the APC and MLH1 genes: the worst of two worldsR Scheenstra, F E M Rijcken, J J Koornstra, et al.
Clinical Genetics|December 1, 2010
Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test resultsJ Vos, J C Oosterwijk, E Gómez-García, et al.
Gynecologic Oncology|January 6, 2000
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.
International Journal of Cancer|July 15, 1990
The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the NetherlandsH F Vasen, G J Offerhaus, F C den Hartog Jager, et al.
Pageof 9